SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-039889
Filing Date
2019-07-11
Accepted
2019-07-11 08:10:37
Documents
7
Period of Report
2019-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12679_48k.htm 8-K 45283
2 EX-5.1 a19-12679_4ex5d1.htm EX-5.1 10533
3 EX-10.1 a19-12679_4ex10d1.htm EX-10.1 262182
4 EX-10.2 a19-12679_4ex10d2.htm EX-10.2 373189
5 EX-10.3 a19-12679_4ex10d3.htm EX-10.3 120584
6 EX-99.1 a19-12679_4ex99d1.htm EX-99.1 15775
7 GRAPHIC g126794mmi001.jpg GRAPHIC 2851
  Complete submission text file 0001104659-19-039889.txt   832936
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 19950352
SIC: 2834 Pharmaceutical Preparations